Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) COO Sells 20,000 Shares of Stock
Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) COO Cortney Caudill sold 20,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was sold at an average price...